377 related articles for article (PubMed ID: 11567988)
1. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
Kollman C; Howe CW; Anasetti C; Antin JH; Davies SM; Filipovich AH; Hegland J; Kamani N; Kernan NA; King R; Ratanatharathorn V; Weisdorf D; Confer DL
Blood; 2001 Oct; 98(7):2043-51. PubMed ID: 11567988
[TBL] [Abstract][Full Text] [Related]
2. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
Drobyski WR; Klein J; Flomenberg N; Pietryga D; Vesole DH; Margolis DA; Keever-Taylor CA
Blood; 2002 Feb; 99(3):806-14. PubMed ID: 11806980
[TBL] [Abstract][Full Text] [Related]
3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
6. Treatment of CML with unrelated donor marrow transplant.
McGlave P
Leuk Lymphoma; 1993; 11 Suppl 1():209-11. PubMed ID: 8251898
[TBL] [Abstract][Full Text] [Related]
7. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
[TBL] [Abstract][Full Text] [Related]
8. Use of partially mismatched related donors extends access to allogeneic marrow transplant.
Henslee-Downey PJ; Abhyankar SH; Parrish RS; Pati AR; Godder KT; Neglia WJ; Goon-Johnson KS; Geier SS; Lee CG; Gee AP
Blood; 1997 May; 89(10):3864-72. PubMed ID: 9160695
[TBL] [Abstract][Full Text] [Related]
9. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
[TBL] [Abstract][Full Text] [Related]
10. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
[TBL] [Abstract][Full Text] [Related]
11. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
[TBL] [Abstract][Full Text] [Related]
12. Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.
Alyea EP; Weller E; Fisher DC; Freedman AS; Gribben JG; Lee S; Schlossman RL; Stone RM; Friedberg J; DeAngelo D; Liney D; Windawi S; Ng A; Mauch P; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2002; 8(11):601-7. PubMed ID: 12463479
[TBL] [Abstract][Full Text] [Related]
13. Unrelated donor marrow transplantation in children.
Balduzzi A; Gooley T; Anasetti C; Sanders JE; Martin PJ; Petersdorf EW; Appelbaum FR; Buckner CD; Matthews D; Storb R; Sullivan KM; Hansen JA
Blood; 1995 Oct; 86(8):3247-56. PubMed ID: 7579422
[TBL] [Abstract][Full Text] [Related]
14. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
15. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
18. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
Castro-Malaspina H; Harris RE; Gajewski J; Ramsay N; Collins R; Dharan B; King R; Deeg HJ
Blood; 2002 Mar; 99(6):1943-51. PubMed ID: 11877264
[TBL] [Abstract][Full Text] [Related]
19. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
20. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.
Enright H; Davies SM; DeFor T; Shu X; Weisdorf D; Miller W; Ramsay NK; Arthur D; Verfaillie C; Miller J; Kersey J; McGlave P
Blood; 1996 Jul; 88(2):714-20. PubMed ID: 8695820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
